Innovative Biosensor Platforms for the Detection of Metformin in Diabetes Management
Sajjad Jafarzadeh1, Elham Shaterian2, Samira Jafarisis3
1Department of Stem Cells and Developmental Biology, Cell Sciences Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran, acecr.ac.ir.
International Journal of Analytical Chemistry
|June 8, 2026
Summary
This review highlights advanced biosensor technologies for detecting metformin, a key Type 2 diabetes drug. These innovations are crucial for optimizing treatment and improving patient adherence in diabetes management.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Pharmacology
Background:
- Metformin is a primary antihyperglycemic agent for Type 2 diabetes management.
- Effective glucose regulation necessitates precise monitoring of metformin drug levels.
- Rising global diabetes prevalence underscores the need for advanced monitoring solutions.
Purpose of the Study:
- To review contemporary biosensor technologies for sensitive metformin detection.
- To emphasize the significance of these biosensors in clinical and pharmaceutical settings.
- To explore the role of nanomaterials in enhancing biosensor performance.
Main Methods:
- Analysis of electrochemical, optical, and piezoelectric biosensor platforms.
- Evaluation of biosensor principles, advantages, and limitations.
- Discussion of nanomaterial integration for improved sensitivity and specificity.
Main Results:
- Various biosensor platforms show promise for metformin detection.
- Nanomaterials significantly enhance sensitivity and specificity in biosensing.
- Current technologies offer potential for improved therapeutic drug monitoring.
Conclusions:
- Innovative biosensing strategies are vital for effective metformin management.
- Advancements in biosensors can improve patient outcomes and treatment adherence.
- Further research in biosensor development is crucial for diabetes care.
Related Concept Videos
01:17Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...